Breast cancer prevention by short-term inhibition of TGFβ signaling

TGF-β signaling in tumor suppression and cancer progression

Reprogramming of cancer-associated fibroblasts by apoptotic cancer

Frontiers Breast Cancer Resistance to Cyclin-Dependent Kinases 4

Targeting transforming growth factor-β signaling for enhanced

Figure S5. Immunofluorescence analysis of Ki67 and p27 in mammary gland

Kornelia POLYAK, Professor (Full), MDPhD, Dana-Farber Cancer Institute, Boston, DFCI, Department of Medical Oncology

Targeting the TGFβ signalling pathway in disease

Research progress on drugs targeting the TGF-β signaling pathway

Frontiers The Signaling Pathways Associated With Breast Cancer

Marco SEEHAWER, Dana-Farber Cancer Institute, Boston, DFCI, Department of Medical Oncology

Signaling pathways in cancer-associated fibroblasts and targeted

Frontiers New Advances in Targeted Therapy of HER2-Negative

Stem Cells and the Differentiation Hierarchy in Mammary Gland Development